Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration

被引：0

作者：

Miguel Senabre-Gallego, Jose ^{[1
]}

Rosas, Jose ^{[1
]}

Llinares-Tello, Francisca ^{[2
]}

Marco-Mingot, Mariana ^{[2
]}

Pons, Ana ^{[1
]}

Barber, Xavier ^{[3
]}

Santos-Soler, Gregorio ^{[1
]}

Salas-Heredia, Esteban ^{[1
]}

Cano, Catalina ^{[1
]}

Lorente, Marisa ^{[1
]}

Sanchis, Marina ^{[3
]}

Molina, Juan ^{[2
]}

Garcia-Carrasco, Mario ^{[4
]}

机构：

[1] Hosp Marina Baixa, Rheumatol, Villajoyosa, Alicante, Spain

[2] Hosp Marina Baixa, Villajoyosa, Alicante, Spain

[3] Univ Miguel Hernandez, CIO, Elche, Spain

[4] HGR 36 CIBIOR Inst Mexicano Seguro Social, Syst Autoimmune Dis Res Unit, Puebla, Mexico

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

620

引用

页数：2

共 50 条

[41] Monitoring Hepatitis B Screening Compliance in Patients with Rheumatoid Arthritis (RA) Receiving Anti-TNF Therapy
Panthulu, Vedashree
Waterman, John
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[42] Acid sphingomyelinase activity is elevated in the serum of rheumatoid arthritis patients, suppressed by anti-TNF-α treatment
Chung, H. -Y.
Wickel, J.
Stuhlmueller, B.
Kinne, R. W.
Claus, R. A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : S18 - S19
[43] Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-α therapy
Krishnamurthy, Raghu
Dincer, H. Erhan
Whittemore, Darren
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (03) : 150 - 152
[44] Serum adiponectin as a predictor of laboratory response to anti-TNF-α therapy in rheumatoid arthritis
Sikorska, Dorota
Rutkowski, Rafal
Luczak, Joanna
Samborski, Wlodzimierz
Witowski, Janusz
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 43 (03) : 289 - 294
[45] Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy
De Stefano, R.
Frati, E.
Nargi, F.
Menza, L.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 752 - 753
[46] Rapid resolution of gastrointestinal amyloidosis and resolution of proteinuria in patients with rheumatoid arthritis treated with anti-TNF-α therapy
Kuroda, Takeshi
Kobayashi, Daisuke
Otaki, Yasuhiro
Sato, Hiroe
Nakatsue, Takeshi
Wada, Yoko
Murakami, Shuichi
Saeki, Takako
Nakano, Masaaki
Hanyu, Tadamasa
Gejyo, Fumitake
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S270 - S270
[47] Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy
Gonzalez-Gay, M. A.
Vazquez-Rodriguez, T. R.
Garcia-Unzueta, M. T.
Berja, A.
Miranda-Filloy, J. A.
de Matias, J. M.
Gonzalez-Juanatey, C.
Llorca, J.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (01) : 56 - 62
[48] Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
Joulfayan, Haroutyun
Makunts, Tigran
Abagyan, Ruben
SCIENTIFIC REPORTS, 2023, 13 (01)
[49] Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data
Haroutyun Joulfayan
Tigran Makunts
Ruben Abagyan
Scientific Reports, 13
[50] The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients
van Hoogmoed, D.
Fransen, J.
Repping-Wuts, H.
Spee, L.
Bleijenberg, G.
van Riel, P. L. C. M.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (01) : 15 - 19

← 1 2 3 4 5 →